معرفی
Jordan Sloshower, MD, MSc is a Clinical Instructor in the Yale Department of Psychiatry, specializing in psychedelic medicine. He co-founded the Yale Psychedelic Science Group and has led clinical trials of psilocybin therapy. His work integrates psychedelic treatments with psychotherapy and cultural practices. He serves on the Board of Directors of the American Psychedelic Practitioners Association and trains facilitators in psilocybin therapy.
Education:
- MD: Yale University School of Medicine (2014)
- MSc: University of Edinburgh, Medical Anthropology (2007)
- BSc: University of Winnipeg, Bioanthropology (2005)
Research Interests: Focuses on therapeutic applications of psychedelics, particularly in depression treatment. Explores ceremonial plant medicines, Buddhist philosophy, and integrative wellness. Examines historical and ethical dimensions of psychedelic research, including past abuses against marginalized groups.
Publications: Over 20 peer-reviewed articles on psychedelic therapeutics, clinical trials, and ethical frameworks. Recent work includes a field-wide review of psilocybin trials and analysis of ayahuasca policy.
Labs/Teams: Co-founded the Yale Psychedelic Science Group, a multidisciplinary team advancing psychedelic research. Collaborates with MAPS and Usona Institute on MDMA and psilocybin programs.
